India sees a subtle uptick in COVID-19 cases. Understand current trends, new variant symptoms, and essential safety measures to protect yourself and your loved ones. Expert advice included.Know more details :
https://www.mrmed.in/health-library/covid-19/covid-19-cases-india
#IndiaCOVID #COVID19India #PublicHealth #StaySafe #JN1Variant #IndiaFightsCorona #COVIDUpdate #HealthIndia #NewCases #OmicronVariant
#COVID #JN1variant now leading cause of infections in United States, CDC says
https://www.youtube.com/watch?v=uN4wDcN7msY
Do you know what comorbidities are commonly seen in those who have died from the #JN1variant of #COVID19? Read this.
https://thesouthfirst.com/health/death-audit-report-comorbidities-among-people-who-died-due-to-jn-1/
7 out of 10 samples are testing positive for the JN.1 variant of #Covid19.
In December, 3 out of 4 cases were found to be of the #JN1variant.
Despite its ability to rapidly spread, the infection is milder and mostly asymptomatic
"Covid cases may hit a new record in the middle of January after the highly-infectious JN.1 subvariant became the dominant strain over Christmas...
UK infections will keep rising for another week or two to “rival” the country’s two biggest Covid waves, seen early in 2022 – and they “might even exceed them”, according to data scientist Professor Christina Pagel, of University College London...
JN.1 grew from 1 per cent of UK Covid cases at the end of October to account for 5 per cent by mid November..."
#CovidIsNotOver #JN1 #JN1Variant
https://inews.co.uk/news/covid-cases-break-uk-record-january-jn1-variant-2833317
The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.
JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.
"New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
https://www.axios.com/2023/12/26/new-covid-variant-most-cases
JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level
JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
#COVID #COVID19 #JN1variant #Variants #WHO
SCIEU Team
Corona New Variant: 40 देशों में फैला कोरोना का नया सब वैरिएंट JN.1, भारत में बढ़ने लगे केस, केंद्र और राज्य सरकारों ने जारी की एडवाइजरी
#Covid19 #JN1Variant #JN1 #CoronavirusUpdates #COVID19 #NewVarient #Kerala #Coronavirus
@MoHFW #dwsamachar #SubVarie
https://dwsamachar.com/2023/12/21/corona-new-variant-danger-alert-from-40-countries-including-india/
COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability
Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
#Coronavirus #COVID #COVID19 #JN1variant #Variants
Umesh Prasad
@jducoeur #COVID #JN1Variant ”If 35 changes to the spike, lab data showing immune evasion, and associated epidemiological increases don’t qualify for a name change, I’m not sure what will.”
COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability
Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
#Coronavirus #COVID #COVID19 #JN1variant #Variants
Umesh Prasad
新病毒株JN.1（BA2.86的後代）來襲，目前已觀察到/已知：
- 感染佔比⬆️
- 廢水中檢測量⬆️
- 尚未觀察到病症有加重，但不排除有變嚴重的可能性❗️
- 免疫逃避性⬆️
- 過往感染與疫苗接種產生的抗體對其效果極差
- 強烈建議注意衛生與佩戴口罩
該研究指出：
- JN.1 病毒株適應性佳
- ACE2結合能力⬆️
- 具有極強免疫逃避力，EG5.1感染者與接種XBB.1.5的接種者血清中的抗體對其病毒株的中和效架顯著下降
❗️不論施打新疫苗還是感染，體內產生的抗體不足以對抗該新病毒株❗️
🔗：https://biorxiv.org/content/10.1101/2023.12.08.570782v1.full
JN.1 在新加波流動的病毒株中出現擁有NS8 S103L突變的亞型，就過往研究指出其可影響免疫系統識別病毒/受感染細胞的能力
目前臨床上尚未觀察到症狀有嚴重化的趨勢，但仍不能忽視長新冠LongCovid的風險，與其他突變可能帶來的影響
देश में एक बार फिर कोरोना का नया सब वैरिएंट JN1 से बढ़ी दहशत, केरल में चार लोगों की हुई मौत
#COVID19 #NewVarient #Kerala #JN1 #JN1Variant #Coronavirus @MoHFW #subvariant #India #SriLanka #CovidVariant #Omicron #CovidAlert
